Fri, 23 Jul 2021 13:08:07: Novel degrader of cancer-driving protein AKT slows prostate, breast tumors in mice

Fri, 23 Jul 2021 09:37:13: UPDATE: Half of Adverum pipeline 'snaps out of existence' as adverse events force pivot to more common eye disease

Fri, 23 Jul 2021 08:49:54: Lumos delays key hormone deficiency readout as COVID bites

Fri, 23 Jul 2021 08:19:52: Eli Lilly pens pact with Banner Alzheimer's Institute for ‘virtual approach’ for its late-stage donanemab test

Thu, 22 Jul 2021 11:32:12: Seres Therapeutics’ microbiome therapy flops against placebo as shares go into freefall

Thu, 22 Jul 2021 10:34:30: Roche in ‘continued dialogue’ with FDA over Alzheimer’s prospect; culls early-stage assets in Q2 clearout

Wed, 21 Jul 2021 18:26:38: New gene therapy approach shows signs of preventing vision loss from glaucoma

Wed, 21 Jul 2021 13:05:09: AbbVie, Roche top data transparency list, but more could be done to build trust in medical system: report

Wed, 21 Jul 2021 12:43:45: Hemab raises $55M to target multiple rare bleeding indications

Wed, 21 Jul 2021 12:16:00: Vedanta raises $68M, reveals setback to Bristol Myers alliance

Wed, 21 Jul 2021 11:26:06: Coave raises $25M ahead of pivotal retinal gene therapy trial

Wed, 21 Jul 2021 08:41:42: Novartis ditches midstage dry eye drug, gets New Year’s PDUFA data for troubled Leqvio

Wed, 21 Jul 2021 08:40:43: Bayer's drug that turns a cancer-protective pathway toxic eradicates breast tumors in mice

Tue, 20 Jul 2021 13:10:35: Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases

Tue, 20 Jul 2021 11:54:21: In an unusual crossover, Gilead hires Arcus CMO Grossman, putting him in charge of cancer pact with his former biotech

Tue, 20 Jul 2021 11:28:46: Panakčs moves into biotech investing with new €150M fund

Tue, 20 Jul 2021 10:48:53: Ardelyx stock craters as FDA slaps biotech with dreaded ‘deficiencies’ tag on kidney drug

Mon, 19 Jul 2021 12:57:03: Surprise genetic discovery in macular degeneration points to new treatment strategy

Mon, 19 Jul 2021 12:10:41: Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”

Mon, 19 Jul 2021 11:24:26: Adagio seeks IPO to bring COVID-19 antibody to market in 2022

Mon, 19 Jul 2021 09:18:12: Troubled Cytokinetics' stock soars as gets much needed phase 2 heart drug trial win, plans late-stage effort by year’s end

Fri, 16 Jul 2021 14:30:49: Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1,000 new staffers over 5 years

Fri, 16 Jul 2021 10:30:20: Polyphor sharpens ax on staff, shutters failed breast cancer test

Fri, 16 Jul 2021 09:10:43: GSK sells off part of its U.K. R&D site to rake in $554M and boost biotech ops

Thu, 15 Jul 2021 21:38:22: 2 pathways that prepare and kill melanoma cells could inspire novel anti-cancer drugs